Amneal Pharmaceuticals, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 13.94

Amneal Pharmaceuticals, Inc. Debt to Equity Ratio is 13.94 for the Trailing 12 Months (TTM) ending March 31, 2025, a -24.42% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Amneal Pharmaceuticals, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 18.44, a 44.34% change year over year.
  • Amneal Pharmaceuticals, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was 12.78, a 66.82% change year over year.
  • Amneal Pharmaceuticals, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was 7.66, a -17.21% change year over year.
  • Amneal Pharmaceuticals, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was 9.25, a 21.27% change year over year.
Key Data
Date Debt to Equity Ratio Quick Ratio Current Ratio Interest Coverage Ratio